U. V. Maslikova

U. V. Maslikova

Auto-generated profile, based on publicly available information

U. V. Maslikova

National Medical Research Center for Hematology

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2023 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
UMU. V. Maslikova
U. V. Maslikova
NPN. N. Popova
N. N. Popova
MDM. Yu. Drokov
M. Yu. Drokov
EKE. G. Khamaganova
E. G. Khamaganova
Graft failure is a group of complications after allogeneic hematopoietic stem cell transplantation, which occurs according to different data up to 30%. The group of complications includes primary and secondary graft failure, primary, secondary and transient poor graft function and graft rejection. Diagnostic difficulties consist in the lack of unified diagnostic criteria accepted in the transplantation community and in the dual interpretation of these complications according to the foreign literature. The purpose of this literature review was to identify the most common criteria of different types of graft failure and determine the tactics of diagnosis and treatment. In this review we analyzed data from various literature sources, gave definitions of graft failure and poor graft function. We analyzed the literature data on the methods used to treat these conditions.

24 February 2022 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
RSR. A. Sharifova
R. A. Sharifova
ABA. Kh. S. Al Breizat
A. Kh. S. Al Breizat
MKMichael Kaabak
Michael Kaabak
UMU. V. Maslikova
U. V. Maslikova
BYB. I. Yaremin
B. I. Yaremin
Transplantation allows us to confidently save the lives of previously doomed patients. Unfortunately, this colossal achievement of human progress has a problematic side – the shortage of donor organs. The use of animal organs could solve it. Currently, the issues of xenotransplantation have become relevant again after the experimental xenotransplantation of the kidney of a genetically modified pig in 2021, and the xenotransplantation of the heart in 2022. This practice raises a number of ethical questions. Is it ethical to put humanity at risk by saving one person? Is it ethical to limit the civil rights of a xeno-recipient? Will xenotransplantation create another reason for discrimination? Can the creation of xenochimeras be considered an unacceptable interference in the Divine plan from a religious point of view? Is it ethical to use higher animals for xenotransplantation? Will an increase in the number of xenotransplants create a risk of the identity of the human race? Will xenotransplantation create new questions about equitable organ allocation? The sources of scholars of theologians related to the main Abrahamic religions on this topic are analyzed. Consideration of theological approaches to the new ethical problems presented by xenotransplantation does not allow us to find a unanimity of opinion. However, as this new branch of medical science makes concrete clinical progress, the attitude of society, religious leaders and ordinary believers towards it will improve. From an individual point of view, Judaism does not object to xenotransplantation to prolong and save human life, even in the case of non-kosher animals with genetic modifications. The preservation of life outweighs other values almost without exception. Xenotransplantation, even from a pig, is hailed as a life-sustaining medical intervention from a Jewish ethical perspective by most authors. In Christianity, the motivation is to try to follow the example of Jesus Christ in bringing healing to all those in need. While physiological healing is important, the ultimate goal is the overall well-being of the individual, which requires spiritual, mental, and social well-being in addition to physical health. The most correct generalization about Islamic bioethical views on xenotransplantation would be that, given the state of science, the final ethical and legal definition remains ambiguous, but in general, xenotransplantation as a means of saving human life may be acceptable.

28 February 2021 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
UMU. V. Maslikova
U. V. Maslikova
АСА. А. Супильников
А. А. Супильников
ТЕХНОЛОГИИ РАЗРАБОТКИ ПРОГРАММЫ СОДЕЙСТВИЯ ПРИНЯТИЮ РЕШЕНИЯ В ДИАГНОСТИКЕ ЗАБОЛЕВАНИЙ СИСТЕМЫ КРОВИ С ИСПОЛЬЗОВАНИЕМ СВЁРТОЧНЫХ ИСКУССТВЕННЫХ НЕЙРОННЫХ СЕТЕЙ

18 June 2020 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
BYB. I. Yaremin
B. I. Yaremin
PNP. Kh. Nazarov
P. Kh. Nazarov
KAK. F.O. Alekberov
K. F.O. Alekberov
DKD. Yu. Konstantinov
D. Yu. Konstantinov
EKE. V. Kudinova
E. V. Kudinova
MNM. S. Novruzbekov
M. S. Novruzbekov
Changes in current scientific literature and regulatory documents related to the issues of infectious safety in organ and tissue donation have been analyzed. The suggestions have been given for changing the existing practices to meet new challenges. Data on threats to the safety of organ and tissue donation associated with the COVID-19 pandemic have been presented.

1 January 2017 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
BYB. I. Yaremin
B. I. Yaremin
EPE. V. Parabina
E. V. Parabina
UMU. V. Maslikova
U. V. Maslikova
VAV. E. Aleksandrova
V. E. Aleksandrova
Трансплантация почки является одним из наиболее перспективных способов, призванных обеспечить наступление и успешное сохранение беременности у пациенток с терминальной хронической почечной недостаточностью. Многокомпонентная лекарственная терапия у таких пациенток создает риски для развития плода, в первую очередь благодаря тератогенности ингибиторов mTOR-рецепторов и микофенолатов. Кроме того, ингибиторы пролиферативного сигнала имеют сложное взаимодействие с другими лекарственными средствами, что может приводить к развитию дополнительных осложнений. К одному из них следует отнести рабдомиолиз. Приводится описание клинического случая развития острого эпизода обратимого рабдомиолиза у пациентки на фоне приема эверолимуса.

28 August 2021 in Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)
Verified
Journal Article
Open access
PDF file
EPE. V. Parabina
E. V. Parabina
DKD. Yu. Konstantinov
D. Yu. Konstantinov
MKMichael Kaabak
Michael Kaabak
NRN. N. Rappoport
N. N. Rappoport
SPS. Yu. Pushkin
S. Yu. Pushkin
BYB. I. Yaremin
B. I. Yaremin
The aim of this workis to provide basic answers to questions related to the vaccination of solid organ transplant recipients based on the latest literature sources and clinical guidelines. Vaccination of solid organ transplants and persons in constant contact with them is a mandatory measure, the provision of which is a vital measure that effectively reduces the risk of death from COVID-19. Doubts about less effectiveness in conditions of immunosuppression or the potential risk of developing adverse reactions are significantly inferior to the risk of death and the development of severe complications. Until new data become available, the vaccination regimen must strictly comply with the instructions for medical use of the drug. Before transplantation, the patient should be examined according to the screening protocol, and also consulted by the transplant doctor who supervises him. It is possible that whole virion vaccines (CoviVac) have an advantage over others when vaccinating solid organ recipients, but clinical experience in this matter has not yet been obtained.